Ching Chen Chiu
Corporate Officer/Principal bei BELITE BIO, INC
Profil
Ching Chen Chiu is currently the Vice President of Clinical Operations at Belite Bio, Inc. Prior to this, Chiu worked as an Executive Director at EPS International Co. Ltd.
and as a Managing Director and Director at CMIC Asia-Pacific Pte Ltd.
Chiu received a graduate degree from the University of Warwick and an undergraduate degree from Taipei Medical University.
Aktive Positionen von Ching Chen Chiu
Unternehmen | Position | Beginn |
---|---|---|
BELITE BIO, INC | Corporate Officer/Principal | 01.11.2021 |
Ehemalige bekannte Positionen von Ching Chen Chiu
Unternehmen | Position | Ende |
---|---|---|
CMIC Asia-Pacific Pte Ltd. | Chief Executive Officer | - |
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Director/Board Member | - |
Ausbildung von Ching Chen Chiu
University of Warwick | Graduate Degree |
Taipei Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BELITE BIO, INC | Health Technology |
Private Unternehmen | 2 |
---|---|
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Commercial Services |
CMIC Asia-Pacific Pte Ltd. |